We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
-21.98%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
$0
Cap. Flow
-$63.6K
Cap. Flow %
-0%
Top 10 Hldgs %
13.08%
Holding
3,173
New
–
Increased
3
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
+$51.9K
2
OVV icon
Ovintiv
OVV
+$14.7K
3
VANI icon
Vivani Medical
VANI
+$119

Top Sells

Rank Stock Value
1
BIP icon
Brookfield Infrastructure Partners
BIP
+$78.8K
2
TU icon
Telus
TU
+$37K
3
ODFL icon
Old Dominion Freight Line
ODFL
+$14.5K
4
BBBY
Bed Bath & Beyond
BBBY
+$11

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NLY icon
1201
Annaly Capital Management
NLY
$17.1B
$101K ﹤0.01%
2,700
– –
PRLB icon
1202
Protolabs
PRLB
$1.79B
$101K ﹤0.01%
999
– –
UHAL icon
1203
U-Haul Holding Co
UHAL
$13.9B
$101K ﹤0.01%
2,700
– –
PGTI
1204
DELISTED
PGT, Inc.
PGTI
$101K ﹤0.01%
6,835
– –
ANZ
1205
DELISTED
AUSTRALIA & NW ZEAL ADS(RP5 SH
ANZ
$101K ﹤0.01%
5,846
– –
HES
1206
DELISTED
Hess
HES
$100K ﹤0.01%
1,505
– –
OIH icon
1207
VanEck Oil Services ETF
OIH
$2.06B
$99K ﹤0.01%
375
– –
CRTO icon
1208
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$98K ﹤0.01%
5,668
– –
TMUS icon
1209
T-Mobile US
TMUS
$185B
$98K ﹤0.01%
1,261
– –
SRNE
1210
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$98K ﹤0.01%
29,135
– –
NJ
1211
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$98K ﹤0.01%
2,844
– –
MACE
1212
DELISTED
MACE SECURITY INTL INC NEW
MACE
$98K ﹤0.01%
395,610
– –
AERI
1213
DELISTED
Aerie Pharmaceuticals
AERI
$97K ﹤0.01%
4,024
– –
APA icon
1214
APA Corp
APA
$13.2B
$96K ﹤0.01%
3,776
– –
NWN icon
1215
Northwest Natural Holdings
NWN
$2.06B
$96K ﹤0.01%
1,311
– –
UNM icon
1216
Unum
UNM
$13.6B
$96K ﹤0.01%
3,306
– –
IMMU
1217
DELISTED
Immunomedics Inc
IMMU
$95K ﹤0.01%
4,533
– –
BIDU icon
1218
Baidu
BIDU
$37.7B
$94K ﹤0.01%
751
– –
TWTR
1219
DELISTED
Twitter, Inc.
TWTR
$94K ﹤0.01%
2,957
– –
ECHO
1220
DELISTED
Echo Global Logistics, Inc.
ECHO
$94K ﹤0.01%
4,553
– –
AYI icon
1221
Acuity Brands
AYI
$9.83B
$93K ﹤0.01%
676
– –
BEP icon
1222
Brookfield Renewable
BEP
$9.97B
$93K ﹤0.01%
3,753
– –
BL icon
1223
BlackLine
BL
$1.84B
$93K ﹤0.01%
1,810
– –
CGC
1224
Canopy Growth
CGC
$387M
$93K ﹤0.01%
446
– –
CHEF icon
1225
Chefs' Warehouse
CHEF
$4.71B
$93K ﹤0.01%
2,448
– –
47 48
49
50 51

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q1 2020 Portfolio in Review

As of Q1 2020, Glenmede Trust held 3,173 positions worth $21.9B, unchanged from the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Glenmede Trust opened no new positions and made no exits, leaving the 3,173-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, unchanged from a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust added most to Interpace Biosciences, Inc. Common Stock in Q1 2020, an estimated $51.9K increase.
  • Glenmede Trust's biggest Q1 2020 reduction was Brookfield Infrastructure Partners, cutting an estimated $78.8K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q1 2020.
  • Glenmede Trust opened 0 new positions and closed 0 in Q1 2020.
  • Glenmede Trust's portfolio value was unchanged quarter-over-quarter at $21.9B.

Based on Glenmede Trust's 13F filing for Q1 2020, filed 20 May 2020.